Daniel C. Javitt, 10% Owner at NRX Pharmaceuticals, Inc. (NRXP), sold 300,456 shares at $1.02 ($307K) on 2022-11-16, disclosed to the SEC on 2022-11-18.
Open-market sale of $307k NRXP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.02 | 133,719 | $136K | 44.4% |
| 2 | $1.02 | 133,719 | $136K | 44.4% |
| 3 | $1.05 | 33,018 | $35K | 11.3% |
| Total | $1.02 avg | 300,456 | $307K | 100% |
| Filing → |
| NRXP | SELL | 2022-08-02 | $1.6M | — | Filing → |
| NRXP | SELL | 2022-06-07 | $608K | — | Filing → |